Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice
about
Dramatically decreased high density lipoprotein cholesterol, increased remnant clearance, and insulin hypersensitivity in apolipoprotein A-II knockout mice suggest a complex role for apolipoprotein A-II in atherosclerosis susceptibilityApolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.Inhibition of ABCA1 protein degradation promotes HDL cholesterol efflux capacity and RCT and reduces atherosclerosis in mice.Rosuvastatin does not affect human apolipoprotein A-I expression in genetically modified mice: a clue to the disputed effect of statins on HDLExpression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolismHuman ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic miceTransgenic mouse models of lipoprotein metabolism and atherosclerosisEffect of leucine to phenylalanine substitution on the nonpolar face of a class A amphipathic helical peptide on its interaction with lipid: high resolution solution NMR studies of 4F-dimyristoylphosphatidylcholine discoidal complex.Influence of apolipoprotein A-I and apolipoprotein A-II availability on nascent HDL heterogeneityReduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.Substitution of the carboxyl-terminal domain of apo AI with apo AII sequences restores the potential of HDL to reduce the progression of atherosclerosis in apo E knockout miceTwo regulatory elements of similar structure and placed in tandem account for the repressive activity of the first intron of the human apolipoprotein A-II gene.AMPK activation enhances the anti-atherogenic effects of high density lipoproteins in apoE-/- mice.
P2860
Q28586230-CDA8D9F3-9F9B-4F49-AF96-68B118988A6AQ34119817-BEE39CE9-7AB6-4CF8-AA0A-455C6FF9EA3DQ35536404-8973FD76-D195-4998-AF5B-088E91FF44EAQ35564280-F7EB8EA9-1B09-487C-A8A4-C00C6631748FQ35763106-8FC6227E-6AA8-4C92-ADF6-F6CEAD5E8B89Q35824669-D2F4B07C-68CB-44A4-A235-485FD116F726Q36525382-983EB8A5-092A-4791-BD07-97C24F880C23Q36990191-E4A159B6-32CF-4E50-A244-7FBFC487E86AQ37305412-0752770B-0F00-41A4-A43B-D30F878E9530Q37365875-AA4EE121-33E0-49F1-BA97-A5B6A6121378Q37383939-CF27D10F-C692-436A-BBD4-98C8C1168406Q41172042-60B9355C-C5BB-435E-8F32-FB23571F2FC8Q42879466-2E05B8C3-266F-4AB1-AB3B-4B313B76EC96
P2860
Expression of human apolipoprotein A-II and its effect on high density lipoproteins in transgenic mice
description
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Journal of Biological Chemistry
@fr
artículu científicu espublizáu en 1992
@ast
im Oktober 1992 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1992/10/25)
@sk
vědecký článek publikovaný v roce 1992
@cs
wetenschappelijk artikel (gepubliceerd op 1992/10/25)
@nl
наукова стаття, опублікована в жовтні 1992
@uk
name
Expression of human apolipopro ...... ipoproteins in transgenic mice
@ast
Expression of human apolipopro ...... ipoproteins in transgenic mice
@en
Expression of human apolipopro ...... ipoproteins in transgenic mice
@nl
type
label
Expression of human apolipopro ...... ipoproteins in transgenic mice
@ast
Expression of human apolipopro ...... ipoproteins in transgenic mice
@en
Expression of human apolipopro ...... ipoproteins in transgenic mice
@nl
prefLabel
Expression of human apolipopro ...... ipoproteins in transgenic mice
@ast
Expression of human apolipopro ...... ipoproteins in transgenic mice
@en
Expression of human apolipopro ...... ipoproteins in transgenic mice
@nl
P2093
P1476
Expression of human apolipopro ...... ipoproteins in transgenic mice
@en
P2093
A. V. Nichols
E. L. Gong
E. M. Rubin
J. R. Schultz
M. R. McCall
S. M. Clift
P304
21630–21636
P407
P577
1992-10-25T00:00:00Z